This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated CYC1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-CYC1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~35.4 kDa | |
| Observed band | ~33 kDa | |
| Gel | 5–20% (catalog A02958-2) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A02958-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human A431, human Hela, human MCF-7 (catalog A02958-2) |
| Gel % | 5–20% (catalog A02958-2) |
| Load | 30 ug; reducing conditions (catalog A02958-2) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A02958-2) |
| Membrane | nitrocellulose membrane (catalog A02958-2) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A02958-2) |
| Primary antibody | A02958-2 · 0.5 μg/mL (catalog A02958-2) |
| Primary incubation | overnight at 4°C (catalog A02958-2) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A02958-2) |
| Secondary incubation | 1.5 hour at RT (catalog A02958-2) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A02958-2) |
| Detection | ECL (catalog A02958-2) |
CYC1 is predicted at 35.4 kDa and observed at ~33 kDa on reducing Western blots; the cause of the difference is not established.
| Band at ~33 kDa | Empirical CYC1 band reported in reducing whole-cell lysates; confirm identity with antibody controls |
| Band near 35.4 kDa | Consistent with the predicted CYC1 mass, though migration may differ |
| Weak band in poorly solubilized lysate | CYC1 is a single-pass mitochondrial inner-membrane protein |
| Close doublet near ~33 kDa | Ser182 phosphorylation is documented, but its effect on migration is unestablished |
| Predicted CYC1 mass | 35.4 kDa is the sequence-based reference, versus the observed ~33 kDa band |
| Phosphoserine at Ser182 | A modification is documented, but no apparent-size change is established |
| Single-pass inner-membrane location | May affect recovery; no apparent-size change is established |
| Complex III membership | CYC1 belongs to a multisubunit complex; no SDS-PAGE size effect is established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Poor recovery of mitochondrial inner-membrane CYC1 | Check membrane solubilization and use a mitochondrial fraction as a control |
| Band higher than expected | Identity or migration of the higher band is unestablished | Compare reducing samples with the ~33 kDa reference and verify antibody specificity |
| Band lower than expected | The reported ~33 kDa band runs below the 35.4 kDa prediction for an unknown reason | Compare with the reported band and confirm identity using an independent antibody or CYC1 depletion |
| Multiple bands | Additional bands are not explained by listed isoforms | Identify the ~33 kDa band using CYC1 depletion or an independent antibody |
| Weak or no signal | Incomplete extraction of single-pass mitochondrial membrane CYC1 | Optimize membrane solubilization and check sample loading |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cerebellum | Purkinje cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Caudate | glial cells | Low | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Medium | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Cerebral cortex | endothelial cells | Medium | Protein (IHC) | HPA → |
| Cervix | glandular cells | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for CYC1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A02958-2 is a human-reactive anti-CYC1 antibody with a Western blot image from A431, HeLa, and MCF-7 whole-cell lysates. The caption reports a band near 33 kDa versus the expected 35 kDa; no independent validation is supplied.
Which to pick: Only A02958-2 is listed. Choose it for human CYC1 Western blots when its documented whole-cell lysate conditions fit your experiment. Performance in other species or specimen types is not established here.